newsfilter
← Latest News
Business Wire·

Satellos to Participate in Oppenheimer Movers in Rare Disease Summit

Satellos Bioscience Inc. (TSX:MSCL, OTCQB:MSCLF) ("Satellos"), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, announced today